LEADER 04263nam  22006015  450 
001 9910254490203321
005 20200702071944.0
010   $a3-319-60600-X
024 7 $a10.1007/978-3-319-60600-2
035   $a(CKB)3710000001631490
035   $a(MiAaPQ)EBC4942040
035   $a(DE-He213)978-3-319-60600-2
035   $a(PPN)20385358X
035   $a(EXLCZ)993710000001631490
100   $a20170809d2017      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aNovel Psychoactive Substances $ePolicy, Economics and Drug Regulation /$fedited by Ornella Corazza, Andres Roman-Urrestarazu
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017.
215   $a1 online resource (177 pages)
311   $a3-319-60599-2 
320   $aIncludes bibliographical references at the end of each chapters.
327   $a1.The Global Emergence of NPS: An Analysis of a New Drug Trend -- 2.Legislating NPS in the European Union -- 3.Regulation as Global Drug Governance ? How New is the NPS Phenomenon? -- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport -- 5.Exploring Novel Policy Responses to NPS and ?legal highs? in New Zealand, Poland, Republic of Ireland and the United Kingdom -- 6.Regulating NPS in the Middle East: A Critical Juncture -- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals -- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom -- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach? -- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst?s Perspective -- 11.Harmonizing NPS Legislation Across the European Union: An Utopia? -- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.
330   $aIn light of the recent emergence of New Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory measures. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and public health.
606   $aMedical economics
606   $aPublic health
606   $aPharmacy
606   $aHealth services administration
606   $aHealth services administration
606   $aHealth Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W35000
606   $aPublic Health$3https://scigraph.springernature.com/ontologies/product-market-codes/H27002
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
606   $aHealth Care Management$3https://scigraph.springernature.com/ontologies/product-market-codes/527030
615  0$aMedical economics.
615  0$aPublic health.
615  0$aPharmacy.
615  0$aHealth services administration.
615  0$aHealth services administration.
615 14$aHealth Economics.
615 24$aPublic Health.
615 24$aPharmacy.
615 24$aHealth Care Management.
676   $a615.788
702   $aCorazza$b Ornella$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aRoman-Urrestarazu$b Andres$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254490203321
996   $aNovel Psychoactive Substances$91757768
997   $aUNINA